Digitizing Life Sciences: The Revolution Is Here (Again)

August 10, 2018

By now, the story is familiar: new techniques in AI and data analysis are revolutionizing business decisions and driving productivity, innovation, and efficiency across the enterprise.

Has this revolution come to life sciences? Is it poised to reshape the pharmaceutical industry, where product development is hard to do and even harder to scale, and where each subsequent year of growth is harder to achieve?

Historically, the industry has struggled to adopt “one phrase solutions” to big problems. Efforts to lock up intellectual property through genomic sequencing or create value through M&A have either produced mixed results or failed outright.

So where does this leave you? In this article, we’ll draw on lessons from early efforts to drive big data and advanced analytics in life sciences, explore the most tangible opportunities, and offer a 6-step framework for making successful digital decisions.

Previous Flipbook
BTG Key Strengths: Market Access, Value & Reimbursement
BTG Key Strengths: Market Access, Value & Reimbursement

Get expert advice and seasoned project managers for all your market access, value, and reimbursement initia...

Next Article
Improving A Business Plan
Improving A Business Plan

The director of one of a life science company’s business units was hoping to reduce the size and complexity...

Get our free guide to working with on-demand talent.

Read Now